Two collaborative projects between pharma companies and local NHS bodies received awards at the annual dinner of the ABPI last week.
One project to be recognised was INFORCE, a joint working project between NHS Nottingham City primary care trust, Nottingham University Hospitals NHS Trust and companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Nycomed and Pfizer.
The second collaboration to receive an award was between GlaxoSmithKline and StHealth PBC consortium – the largest PBC group within NHS Halton and St Helens.
Presenting the awards, ABPI Director General Dr Richard Barker said: “The UK-based pharmaceutical industry is working together with the NHS throughout the country on a whole variety of projects, and the success of these projects is a tremendous example of the power of this approach.”
Both projects aim to help patients with chronic obstructive pulmonary disease (COPD).
INFORCE, which was equally funded by all partners, was designed to cut the number of people admitted to hospital with exacerbation of COPD by understanding how their care has been undertaken and making changes to improve it.
“The scheme has been recognised nationally by the Department of Health respiratory policy team as an example of good practice and features as a case study from which it is hoped other PCTs will learn,” said Jan Balmer, who has been helping to lead the INFORCE project.
“Winning this award is a tribute to the far-sightedness and hard work that has gone into helping people with COPD, and is an excellent example of how the NHS and the pharmaceutical industry can co-operate successfully to provide better services for patients.”
The Halton and St Helens project was designed to improve the treatment and care of people with COPD by training healthcare professionals to manage patients in the community and reducing the number of unplanned hospital attendances.
“We are very proud of the achievements made through this collaboration with
GlaxoSmithKline,” said Andrea Gupta, Registered General Nurse and Business Manager at the StHealth PBC Consortium. “The scheme has brought benefits to patients and to all those taking part in a disease area which has been of considerable concern to the NHS in this area.”